OPKO Health Director Buys $11,400 in Stock

Insider purchase signals management confidence in the company's prospects

Mar. 21, 2026 at 12:42pm

Got story updates? Submit your updates here. ›

OPKO Health, Inc. (NASDAQ:OPK) Director John Paganelli purchased 10,000 shares of the company's stock at an average price of $1.14 per share, totaling $11,400. The purchase increased Paganelli's ownership stake in OPKO to 394,340 shares. Insider buying can often signal management's confidence in a company's future performance and provide short-term support for the stock price.

Why it matters

OPKO Health is a diversified healthcare company focused on diagnostics, pharmaceuticals, and biologics development. Insider purchases, like this one by Director Paganelli, can be viewed as a positive signal about the company's prospects, especially given the stock's recent decline. However, the company has also faced some headwinds, including revenue declines and concentration risk, which have led analysts to lower their earnings forecasts.

The details

In the transaction, Director John Paganelli purchased 10,000 shares of OPKO Health stock at an average price of $1.14 per share. This increased his total ownership stake in the company to 394,340 shares. Insider purchases can often be interpreted as a sign that company insiders believe the stock is undervalued and expect it to rise in the future.

  • The stock purchase was made on Friday, March 20, 2026.

The players

John Paganelli

Director of OPKO Health, Inc.

OPKO Health, Inc.

A diversified global healthcare company focused on diagnostics, pharmaceuticals, and biologics development.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

This insider purchase by an OPKO Health director suggests management's confidence in the company's future prospects, despite recent headwinds like revenue declines and lowered earnings forecasts. Investors will be watching to see if this insider buying provides short-term support for the stock price.